International group evaluates tamoxifen risks for women.
作者信息
Court C
出版信息
BMJ. 1996 Mar 2;312(7030):529. doi: 10.1136/bmj.312.7030.529.
PMID:8595274
Abstract
摘要
相似文献
1
International group evaluates tamoxifen risks for women.国际组织评估他莫昔芬对女性的风险。
BMJ. 1996 Mar 2;312(7030):529. doi: 10.1136/bmj.312.7030.529.
2
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):65-6; author reply 67. doi: 10.1016/S0140-6736(05)71562-2.
3
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(00)03579-0.
4
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):65; author reply 67. doi: 10.1016/S0140-6736(05)71561-0.
5
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):66-7. doi: 10.1016/S0140-6736(05)71563-4.
6
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71566-X.
7
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):68. doi: 10.1016/S0140-6736(05)71567-1.
8
Tamoxifen and risk of endometrial cancer.他莫昔芬与子宫内膜癌风险
Lancet. 2001 Jan 6;357(9249):67-8. doi: 10.1016/s0140-6736(05)71565-8.
9
Identification of women at high risk of developing endometrial cancer on tamoxifen.识别服用他莫昔芬后发生子宫内膜癌高危风险的女性。
Eur J Cancer. 2000 Sep;36 Suppl 4:S35-6. doi: 10.1016/s0959-8049(00)00217-3.
10
Monitoring for endometrial disorders in 406 breast cancer women treated by tamoxifen. a low aggressive strategy.
Eur J Cancer. 2000 Sep;36 Suppl 4:S39-40. doi: 10.1016/s0959-8049(00)00218-5.
引用本文的文献
1
Adjuvant treatment with tamoxifen. Care is necessary.他莫昔芬辅助治疗。需谨慎。
BMJ. 1996 Aug 24;313(7055):493-4. doi: 10.1136/bmj.313.7055.493c.
Zotero 插件